Most Active Stories
- Crashed Air Force drone was flying with gear that couldn't handle cold
- Empire Brewing Company says new brewery will create distinctive craft beers
- Schumer hopes federal funds will help local brewpub expand
- Teachers union not ready to reverse no confidence vote in education commissioner
- Small group protests possibility of housing Central American immigrants in Syraucse
Nestle To Buy Pfizer's Infant-Nutrition Line
Originally published on Mon April 23, 2012 7:09 am
RENEE MONTAGNE, HOST:
NPR's business news starts with an acquisition for Nestle.
(SOUNDBITE OF MUSIC)
MONTAGNE: Swiss food company Nestle announced today that it buy the infant nutrition business from the pharmaceutical company Pfizer. The move is likely aimed at boosting Nestle's presence in China. Nestle is paying just under $12 billion. It estimates 85 percent of this year's sales for that Pfizer unit will come from emerging markets. Before announcing this purchase, Nestle already had the largest share of the global baby-formula market at just under 20 percent. Transcript provided by NPR, Copyright NPR.